Electrolytes and Body Fluids — MCQs

Q: Hypokalemia is seen with which of the following?

Furosemide. **Explanation:** **Correct Answer: A. Furosemide** Furosemide is a **Loop diuretic** that inhibits the $Na^+/K^+/2Cl^-$ symporter in the Thick Ascending Limb (TAL) of the Loop of Henle. By preventing sodium reabsorption, it increases the delivery of $Na^+$ to the distal convoluted tubule and collecting ducts. This triggers the $Na^+/K^+$ exchange mechanism (driven by aldosterone), leading to increased potassium secretion into the urine, resulting in **hypokalemia**. **Analysis of Incorrect Options:** * **B. Carbuterol:** This is a $\beta_2$-agonist. While $\beta_2$-agonists (like Salbutamol) actually cause potassium to shift *into* cells by stimulating the $Na^+/K^+$-ATPase pump, leading to transient hypokalemia, Furosemide is the more classic and potent cause of systemic potassium depletion in clinical scenarios. (Note: In some contexts, $\beta_2$-agonists are considered causes, but Furosemide is the definitive pharmacological cause in this MCQ set). * **C. Metabolic Acidosis:** Acidosis typically causes **hyperkalemia**. As excess $H^+$ ions move into the cells to be buffered, $K^+$ ions move out of the cells into the extracellular fluid to maintain electroneutrality. * **D. Amiloride:** This is a **Potassium-sparing diuretic**. It inhibits the Epithelial Sodium Channels (ENaC) in the collecting duct, which reduces the electrical gradient that normally drives $K^+$ secretion, thereby potentially causing hyperkalemia. **High-Yield Clinical Pearls for NEET-PG:** * **Diuretic Rule:** All diuretics cause hypokalemia *except* Potassium-sparing diuretics (Amiloride, Spironolactone, Triamterene). * **Insulin & Alkalosis:** Both cause a "transcellular shift," moving $K^+$ from ECF to ICF, leading to hypokalemia. * **ECG in Hypokalemia:** Look for flattened T-waves, prominent **U-waves**, and ST-segment depression.

Q: Which of the following statements is true about hyperkalemia?

ECG findings are diagnostic.. **Explanation:** **Hyperkalemia** is a critical electrolyte abnormality defined by serum potassium levels. In the context of clinical management and NEET-PG examinations, the diagnostic priority is the **ECG (Electrocardiogram)**. **Why Option C is Correct:** ECG findings are considered **diagnostic of the physiological severity** of hyperkalemia. While a lab report confirms the concentration, the ECG determines the immediate risk of lethal arrhythmias (like Ventricular Fibrillation). Changes occur in a predictable sequence: **Tall peaked T-waves** (earliest sign) → Prolonged PR interval → Loss of P-wave → Widening of QRS complex → **Sine wave pattern** (pre-terminal). Because treatment decisions (like administering Calcium Gluconate) are based on these changes, the ECG is the most vital diagnostic tool. **Why Other Options are Incorrect:** * **Option A:** Management requires stopping *offending* drugs (e.g., ACE inhibitors, Spironolactone), but "all medications" is clinically inappropriate. * **Option B:** This is a **treatment modality**, not a "true statement" defining the condition or its diagnosis. Insulin shifts potassium intracellularly via Na+/K+ ATPase stimulation. * **Option D:** While definitions vary slightly, most standard textbooks (Harrison’s) define hyperkalemia as **>5.0 or >5.5 mmol/L**. 5.2 mmol/L is often considered the upper limit of normal in many labs, making it a less definitive "true" statement compared to the diagnostic importance of the ECG. **High-Yield Clinical Pearls for NEET-PG:** * **Membrane Stabilizer:** Calcium gluconate (10%) is the first-line treatment if ECG changes are present; it stabilizes the myocardium but does *not* lower potassium levels. * **Pseudohyperkalemia:** Always rule this out if there are no ECG changes (caused by hemolysis during venipuncture or thrombocytosis). * **Earliest ECG Change:** Tall, "tented" T-waves in precordial leads.

Q: Edema occurs due to:

Increased capillary permeability. **Explanation:** Edema is the accumulation of excess fluid in the interstitial spaces. Its pathophysiology is governed by **Starling’s Forces**, which dictate the movement of fluid between the capillary and the interstitium. **1. Why Option A is Correct:** **Increased capillary permeability** allows plasma proteins (like albumin) to leak out of the blood vessels into the interstitial space. This increases the **interstitial oncotic pressure** and decreases the **capillary oncotic pressure**, causing fluid to follow the proteins into the tissues. This mechanism is classically seen in **inflammation, burns, and allergic reactions** (type I hypersensitivity). **2. Why the Other Options are Incorrect:** * **B. Decreased capillary permeability:** This would actually make it harder for fluid to leave the vessel, thereby preventing edema. * **C. Decreased interstitial fluid:** This is the definition of dehydration or fluid depletion, the exact opposite of edema. * **D. Decreased blood flow:** While severe ischemia can eventually lead to cell swelling (cytotoxic edema), decreased blood flow generally reduces the **capillary hydrostatic pressure**, which would decrease fluid filtration into the tissues. **High-Yield Clinical Pearls for NEET-PG:** * **Starling’s Equation:** Edema occurs when there is ↑ Capillary Hydrostatic Pressure (e.g., Heart Failure), ↓ Plasma Oncotic Pressure (e.g., Nephrotic Syndrome, Cirrhosis), or ↑ Capillary Permeability. * **Myxedema:** Non-pitting edema caused by the accumulation of glycosaminoglycans (e.g., in Hypothyroidism). * **Safety Factors against Edema:** Low interstitial compliance, increased lymphatic flow, and "washout" of interstitial proteins.

Q: Osmotic adaptations are all except:

Due to urea and glucose mainly. **Explanation:** **Osmotic adaptation** (also known as volume regulation) is a physiological mechanism by which cells, particularly in the brain, protect themselves against sudden shifts in water that could lead to fatal swelling (edema) or shrinkage. **Why Option C is the correct answer (The Exception):** Osmotic adaptation relies on **"Idiogenic Osmoles"** (also called organic osmolytes). These are substances like **taurine, sorbitol, inositol, and betaine**. Urea and glucose are generally considered "ineffective osmoles" (urea crosses membranes freely, and glucose is rapidly metabolized). Therefore, they are **not** the primary substances used for long-term osmotic adaptation. **Analysis of other options:** * **Option A (Due to osmolysis):** Osmolysis refers to the bursting of a cell due to osmotic imbalance. Osmotic adaptation is the cellular response triggered to *prevent* this process. * **Option B (In brain cells):** This is a classic location for this process. The blood-brain barrier and the rigid skull make the brain highly sensitive to volume changes; thus, brain cells are the primary site for generating idiogenic osmoles. * **Option D (Protects against large H₂O shift):** This is the fundamental purpose of the mechanism. By increasing or decreasing internal osmoles, the cell minimizes the osmotic gradient, preventing massive water influx or efflux. **High-Yield Clinical Pearls for NEET-PG:** * **Timeframe:** Osmotic adaptation takes **24–48 hours** to fully develop. * **Clinical Relevance:** This explains why **Chronic Hyponatremia** must be corrected slowly (<8–10 mEq/L in 24h). Rapid correction leads to **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)** because the brain cells cannot shed their idiogenic osmoles fast enough to match the rising extracellular tonicity. * **Key Osmoles:** Remember **Taurine** and **Inositol** as the high-yield examples of idiogenic osmoles.

Q: At what age does the intracellular fluid (ICF) and extracellular fluid (ECF) ratio in a child become equal to that of an adult?

1 year. **Explanation:** The distribution of body fluids undergoes significant changes from birth through infancy. In a newborn, the **Extracellular Fluid (ECF)** volume is relatively high (approx. 40% of body weight) compared to the **Intracellular Fluid (ICF)** volume (approx. 35%). This is due to the physiological immaturity of the kidneys and the high surface-area-to-body-mass ratio. As the infant grows, there is a rapid physiological shift: the ECF volume decreases while the ICF volume increases due to cell growth and multiplication. By **1 year of age (Option A)**, the proportions of ECF and ICF stabilize and reach the adult-like ratio, where ICF (approx. 40% of body weight) is roughly double the ECF (approx. 20% of body weight). **Analysis of Incorrect Options:** * **Options B, C, and D:** While total body water (TBW) continues to decline slightly until puberty, the fundamental shift where ICF becomes the dominant compartment and mirrors adult proportions is completed by the end of the first year. Waiting until age 2, 3, or 4 would be clinically inaccurate as the most dramatic fluid redistribution occurs during the first 12 months of life. **NEET-PG High-Yield Facts:** * **Total Body Water (TBW):** Highest in preterm infants (80%), newborns (75%), and reaches adult levels (60% in males, 50% in females) after puberty. * **ECF vs. ICF:** At birth, ECF > ICF. By 1 year, ICF > ECF. * **Clinical Correlation:** Because infants have a higher ECF-to-ICF ratio and higher TBW, they are more susceptible to rapid dehydration during diarrheal illnesses compared to adults.

Q: 1.5 mL of a solution containing 20 mg/mL of Evans blue dye is injected into plasma. If the final concentration of the dye is 0.015 mg/mL, what is the volume of the plasma?

2 L. ### Explanation **Concept: The Indicator Dilution Principle** The volume of a body fluid compartment can be measured using the formula: **Volume (V) = Amount of substance injected (M) / Final concentration (C)** In this case, Evans blue dye is used because it binds strongly to albumin, making it an ideal marker for measuring **Plasma Volume**. **Calculation:** 1. **Calculate the total amount of dye injected (M):** * Volume injected = 1.5 mL * Concentration = 20 mg/mL * Total Amount = $1.5 \text{ mL} \times 20 \text{ mg/mL} = 30 \text{ mg}$ 2. **Determine the final plasma concentration (C):** * $C = 0.015 \text{ mg/mL}$ 3. **Calculate Plasma Volume (V):** * $V = 30 \text{ mg} / 0.015 \text{ mg/mL} = 2000 \text{ mL}$ * $2000 \text{ mL} = \mathbf{2 \text{ L}}$ **Analysis of Options:** * **Option B (2 L) is correct** based on the mathematical application of the dilution principle. * **Options A, C, and D** are incorrect as they represent mathematical errors in calculating the total initial mass of the dye or incorrect decimal placement during division. **Clinical Pearls for NEET-PG:** * **Markers for Body Fluid Compartments:** * **Total Body Water:** Heavy water ($D_2O$), Tritiated water, Antipyrine. * **Extracellular Fluid (ECF):** Inulin (Gold Standard), Mannitol, Sucrose. * **Plasma Volume:** Evans Blue (T-1824), Radio-iodinated Serum Albumin (RISA). * **Interstitium:** Cannot be measured directly (ECF minus Plasma Volume). * **Intracellular Fluid:** Cannot be measured directly (Total Body Water minus ECF). * **Rule of Thumb:** In a 70 kg adult, plasma volume is typically ~3–3.5 L (approx. 5% of body weight). However, always solve based on the specific values provided in the question.

Q: The kidney plays a role in maintaining the constancy of the milieu interior. What does milieu interior refer to?

Extracellular fluid (ECF). **Explanation:** The term **"Milieu Intérieur"** (Internal Environment) was coined by the French physiologist **Claude Bernard** in the 19th century. It refers specifically to the **Extracellular Fluid (ECF)** that surrounds and bathes the cells. **1. Why ECF is the correct answer:** Cells in multicellular organisms do not live in direct contact with the external atmosphere. Instead, they exist within a "liquid environment"—the ECF. For cells to function optimally, the physical and chemical properties of this fluid (pH, temperature, osmolality, and ion concentrations) must remain constant. This state of stability is known as **Homeostasis** (a term later coined by Walter Cannon). The kidney is the primary organ responsible for regulating the volume and composition of the ECF, thereby maintaining the constancy of the milieu intérieur. **2. Why other options are incorrect:** * **Intracellular Fluid (ICF):** This is the fluid *inside* the cells. While its composition is vital, it is regulated by the cell membrane and the surrounding ECF, rather than being the "internal environment" itself. * **Plasma:** Plasma is a sub-component of the ECF (along with interstitial fluid). While the kidney filters plasma, the term milieu intérieur encompasses the entire fluid environment outside the cells. * **Serum:** Serum is plasma minus clotting factors. It is a laboratory derivative and not a physiological fluid compartment. **High-Yield Facts for NEET-PG:** * **Claude Bernard:** Father of modern physiology; introduced "Milieu Intérieur." * **Walter Cannon:** Coined the term "Homeostasis." * **ECF Volume:** Primarily determined by **Sodium** (the chief extracellular cation). * **Total Body Water (TBW):** 60% of body weight (40% ICF, 20% ECF). The ECF is further divided into Interstitial fluid (3/4th of ECF) and Plasma (1/4th of ECF).

Electrolytes and Body Fluids Indian Medical PG Practice Questions and MCQs

Question 1: Hypokalemia is seen with which of the following?

A. Furosemide (Correct Answer)
B. Carbuterol
C. Metabolic acidosis
D. Amiloride

Explanation: **Explanation:** **Correct Answer: A. Furosemide** Furosemide is a **Loop diuretic** that inhibits the $Na^+/K^+/2Cl^-$ symporter in the Thick Ascending Limb (TAL) of the Loop of Henle. By preventing sodium reabsorption, it increases the delivery of $Na^+$ to the distal convoluted tubule and collecting ducts. This triggers the $Na^+/K^+$ exchange mechanism (driven by aldosterone), leading to increased potassium secretion into the urine, resulting in **hypokalemia**. **Analysis of Incorrect Options:** * **B. Carbuterol:** This is a $\beta_2$-agonist. While $\beta_2$-agonists (like Salbutamol) actually cause potassium to shift *into* cells by stimulating the $Na^+/K^+$-ATPase pump, leading to transient hypokalemia, Furosemide is the more classic and potent cause of systemic potassium depletion in clinical scenarios. (Note: In some contexts, $\beta_2$-agonists are considered causes, but Furosemide is the definitive pharmacological cause in this MCQ set). * **C. Metabolic Acidosis:** Acidosis typically causes **hyperkalemia**. As excess $H^+$ ions move into the cells to be buffered, $K^+$ ions move out of the cells into the extracellular fluid to maintain electroneutrality. * **D. Amiloride:** This is a **Potassium-sparing diuretic**. It inhibits the Epithelial Sodium Channels (ENaC) in the collecting duct, which reduces the electrical gradient that normally drives $K^+$ secretion, thereby potentially causing hyperkalemia. **High-Yield Clinical Pearls for NEET-PG:** * **Diuretic Rule:** All diuretics cause hypokalemia *except* Potassium-sparing diuretics (Amiloride, Spironolactone, Triamterene). * **Insulin & Alkalosis:** Both cause a "transcellular shift," moving $K^+$ from ECF to ICF, leading to hypokalemia. * **ECG in Hypokalemia:** Look for flattened T-waves, prominent **U-waves**, and ST-segment depression.

Question 2: Which of the following statements is true about hyperkalemia?

A. Discontinuation of all medications.
B. Administration of Insulin-Glucose.
C. ECG findings are diagnostic. (Correct Answer)
D. Serum potassium level exceeds 5.2 mmol/L.

Explanation: **Explanation:** **Hyperkalemia** is a critical electrolyte abnormality defined by serum potassium levels. In the context of clinical management and NEET-PG examinations, the diagnostic priority is the **ECG (Electrocardiogram)**. **Why Option C is Correct:** ECG findings are considered **diagnostic of the physiological severity** of hyperkalemia. While a lab report confirms the concentration, the ECG determines the immediate risk of lethal arrhythmias (like Ventricular Fibrillation). Changes occur in a predictable sequence: **Tall peaked T-waves** (earliest sign) → Prolonged PR interval → Loss of P-wave → Widening of QRS complex → **Sine wave pattern** (pre-terminal). Because treatment decisions (like administering Calcium Gluconate) are based on these changes, the ECG is the most vital diagnostic tool. **Why Other Options are Incorrect:** * **Option A:** Management requires stopping *offending* drugs (e.g., ACE inhibitors, Spironolactone), but "all medications" is clinically inappropriate. * **Option B:** This is a **treatment modality**, not a "true statement" defining the condition or its diagnosis. Insulin shifts potassium intracellularly via Na+/K+ ATPase stimulation. * **Option D:** While definitions vary slightly, most standard textbooks (Harrison’s) define hyperkalemia as **>5.0 or >5.5 mmol/L**. 5.2 mmol/L is often considered the upper limit of normal in many labs, making it a less definitive "true" statement compared to the diagnostic importance of the ECG. **High-Yield Clinical Pearls for NEET-PG:** * **Membrane Stabilizer:** Calcium gluconate (10%) is the first-line treatment if ECG changes are present; it stabilizes the myocardium but does *not* lower potassium levels. * **Pseudohyperkalemia:** Always rule this out if there are no ECG changes (caused by hemolysis during venipuncture or thrombocytosis). * **Earliest ECG Change:** Tall, "tented" T-waves in precordial leads.

Question 3: Edema occurs due to:

A. Increased capillary permeability (Correct Answer)
B. Decreased capillary permeability
C. Decreased interstitial fluid
D. Decreased blood flow

Explanation: **Explanation:** Edema is the accumulation of excess fluid in the interstitial spaces. Its pathophysiology is governed by **Starling’s Forces**, which dictate the movement of fluid between the capillary and the interstitium. **1. Why Option A is Correct:** **Increased capillary permeability** allows plasma proteins (like albumin) to leak out of the blood vessels into the interstitial space. This increases the **interstitial oncotic pressure** and decreases the **capillary oncotic pressure**, causing fluid to follow the proteins into the tissues. This mechanism is classically seen in **inflammation, burns, and allergic reactions** (type I hypersensitivity). **2. Why the Other Options are Incorrect:** * **B. Decreased capillary permeability:** This would actually make it harder for fluid to leave the vessel, thereby preventing edema. * **C. Decreased interstitial fluid:** This is the definition of dehydration or fluid depletion, the exact opposite of edema. * **D. Decreased blood flow:** While severe ischemia can eventually lead to cell swelling (cytotoxic edema), decreased blood flow generally reduces the **capillary hydrostatic pressure**, which would decrease fluid filtration into the tissues. **High-Yield Clinical Pearls for NEET-PG:** * **Starling’s Equation:** Edema occurs when there is ↑ Capillary Hydrostatic Pressure (e.g., Heart Failure), ↓ Plasma Oncotic Pressure (e.g., Nephrotic Syndrome, Cirrhosis), or ↑ Capillary Permeability. * **Myxedema:** Non-pitting edema caused by the accumulation of glycosaminoglycans (e.g., in Hypothyroidism). * **Safety Factors against Edema:** Low interstitial compliance, increased lymphatic flow, and "washout" of interstitial proteins.

Question 4: Osmotic adaptations are all except:

A. Due to osmolysis
B. In brain cells
C. Due to urea and glucose mainly (Correct Answer)
D. Protects against large H2O shift

Explanation: **Explanation:** **Osmotic adaptation** (also known as volume regulation) is a physiological mechanism by which cells, particularly in the brain, protect themselves against sudden shifts in water that could lead to fatal swelling (edema) or shrinkage. **Why Option C is the correct answer (The Exception):** Osmotic adaptation relies on **"Idiogenic Osmoles"** (also called organic osmolytes). These are substances like **taurine, sorbitol, inositol, and betaine**. Urea and glucose are generally considered "ineffective osmoles" (urea crosses membranes freely, and glucose is rapidly metabolized). Therefore, they are **not** the primary substances used for long-term osmotic adaptation. **Analysis of other options:** * **Option A (Due to osmolysis):** Osmolysis refers to the bursting of a cell due to osmotic imbalance. Osmotic adaptation is the cellular response triggered to *prevent* this process. * **Option B (In brain cells):** This is a classic location for this process. The blood-brain barrier and the rigid skull make the brain highly sensitive to volume changes; thus, brain cells are the primary site for generating idiogenic osmoles. * **Option D (Protects against large H₂O shift):** This is the fundamental purpose of the mechanism. By increasing or decreasing internal osmoles, the cell minimizes the osmotic gradient, preventing massive water influx or efflux. **High-Yield Clinical Pearls for NEET-PG:** * **Timeframe:** Osmotic adaptation takes **24–48 hours** to fully develop. * **Clinical Relevance:** This explains why **Chronic Hyponatremia** must be corrected slowly (<8–10 mEq/L in 24h). Rapid correction leads to **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)** because the brain cells cannot shed their idiogenic osmoles fast enough to match the rising extracellular tonicity. * **Key Osmoles:** Remember **Taurine** and **Inositol** as the high-yield examples of idiogenic osmoles.

Question 5: At what age does the intracellular fluid (ICF) and extracellular fluid (ECF) ratio in a child become equal to that of an adult?

A. 1 year (Correct Answer)
B. 2 years
C. 3 years
D. 4 years

Explanation: **Explanation:** The distribution of body fluids undergoes significant changes from birth through infancy. In a newborn, the **Extracellular Fluid (ECF)** volume is relatively high (approx. 40% of body weight) compared to the **Intracellular Fluid (ICF)** volume (approx. 35%). This is due to the physiological immaturity of the kidneys and the high surface-area-to-body-mass ratio. As the infant grows, there is a rapid physiological shift: the ECF volume decreases while the ICF volume increases due to cell growth and multiplication. By **1 year of age (Option A)**, the proportions of ECF and ICF stabilize and reach the adult-like ratio, where ICF (approx. 40% of body weight) is roughly double the ECF (approx. 20% of body weight). **Analysis of Incorrect Options:** * **Options B, C, and D:** While total body water (TBW) continues to decline slightly until puberty, the fundamental shift where ICF becomes the dominant compartment and mirrors adult proportions is completed by the end of the first year. Waiting until age 2, 3, or 4 would be clinically inaccurate as the most dramatic fluid redistribution occurs during the first 12 months of life. **NEET-PG High-Yield Facts:** * **Total Body Water (TBW):** Highest in preterm infants (80%), newborns (75%), and reaches adult levels (60% in males, 50% in females) after puberty. * **ECF vs. ICF:** At birth, ECF > ICF. By 1 year, ICF > ECF. * **Clinical Correlation:** Because infants have a higher ECF-to-ICF ratio and higher TBW, they are more susceptible to rapid dehydration during diarrheal illnesses compared to adults.

Question 6: Edema is visible when the amount of fluid accumulated is:

A. 2-3 litres
B. 3-4 litres
C. 4-5 litres
D. 5-6 litres (Correct Answer)

Explanation: **Explanation:** Edema is defined as the palpable or visible swelling produced by an expansion of the interstitial fluid volume. In a healthy adult, the interstitial fluid volume is approximately 11–12 liters. For edema to become clinically detectable (visible), there must be a significant increase in this volume. **Why 5-6 Litres is Correct:** Clinically, "pitting edema" or visible swelling generally does not manifest until the interstitial fluid volume has increased by approximately **10% of the total body weight** or roughly **50% above the normal interstitial volume**. In an average 70 kg adult, this equates to an accumulation of approximately **5 to 6 liters** of excess fluid. This threshold exists because the interstitial matrix has a "negative" compliance (low pressure) that resists fluid accumulation until the pressure becomes positive, at which point fluid accumulates rapidly. **Analysis of Incorrect Options:** * **A (2-3 Litres) & B (3-4 Litres):** While these volumes represent a significant fluid overload, they often result in "occult edema." At this stage, the patient may show weight gain, but the fluid is distributed within the gel-like matrix of the interstitium and is not yet visible as overt swelling. * **C (4-5 Litres):** This is approaching the threshold, but most standard physiological texts (such as Guyton and Ganong) and clinical medicine references (Harrison’s) define the visible threshold closer to the 5-6 liter mark. **High-Yield Clinical Pearls for NEET-PG:** * **Safety Factor against Edema:** There are three main factors (totaling ~17 mmHg) that prevent edema: Low interstitial fluid pressure (-3 mmHg), Lymphatic flow (7 mmHg), and low interstitial protein concentration (7 mmHg). * **First Sign:** The earliest sign of fluid retention is often **weight gain**, not visible edema. * **Pitting vs. Non-pitting:** Pitting edema is usually due to low protein (hypoalbuminemia) or increased hydrostatic pressure (HF). Non-pitting edema is characteristic of lymphedema or myxedema (hypothyroidism).

Question 7: Pseudohyponatremia can be seen in which of the following conditions?

A. Multiple myeloma (Correct Answer)
B. Diarrhea
C. Vomiting
D. Congestive heart failure (CHF)

Explanation: **Explanation:** **Pseudohyponatremia** is a laboratory artifact where the measured serum sodium concentration is low, but the actual plasma osmolality and sodium concentration in the plasma water remain normal. This occurs because sodium is restricted to the aqueous phase of plasma. In conditions with extreme elevations of non-aqueous components (lipids or proteins), the aqueous fraction decreases, leading to an underestimation of sodium when using older flame photometry or indirect ion-selective electrode (ISE) methods. **1. Why Multiple Myeloma is Correct:** In **Multiple Myeloma**, there is a massive production of monoclonal immunoglobulins (paraproteinemia). These excess proteins increase the non-aqueous volume of the plasma sample. Since the laboratory calculates sodium based on the total volume of the sample rather than just the water phase, the reported sodium concentration appears falsely low. **2. Why the Other Options are Incorrect:** * **Diarrhea & Vomiting:** These lead to **true hyponatremia** (or hypernatremia depending on the fluid lost) due to the actual loss of sodium and water from the body (hypovolemic hyponatremia). * **Congestive Heart Failure (CHF):** This causes **dilutional (hypervolemic) hyponatremia**. The decreased effective arterial blood volume triggers ADH release, leading to water retention that physically dilutes the sodium concentration. **High-Yield Clinical Pearls for NEET-PG:** * **Causes of Pseudohyponatremia:** Severe hypertriglyceridemia (chylomicrons) and severe hyperproteinemia (Multiple Myeloma, IVIG therapy). * **Diagnosis:** Suspect pseudohyponatremia if the lab reports low sodium but the **measured serum osmolality is normal** (Osmolar gap). * **Modern Lab Tip:** Direct ISE (often used in ABG machines) does not dilute the sample and is **not** affected by pseudohyponatremia, providing a true sodium level. * **Hyperglycemia** causes "Translocational Hyponatremia" (Hypertonic hyponatremia), which is different from pseudohyponatremia as the osmolality is actually high.

Question 8: 1.5 mL of a solution containing 20 mg/mL of Evans blue dye is injected into plasma. If the final concentration of the dye is 0.015 mg/mL, what is the volume of the plasma?

A. 1 L
B. 2 L (Correct Answer)
C. 3 L
D. 4 L

Explanation: ### Explanation **Concept: The Indicator Dilution Principle** The volume of a body fluid compartment can be measured using the formula: **Volume (V) = Amount of substance injected (M) / Final concentration (C)** In this case, Evans blue dye is used because it binds strongly to albumin, making it an ideal marker for measuring **Plasma Volume**. **Calculation:** 1. **Calculate the total amount of dye injected (M):** * Volume injected = 1.5 mL * Concentration = 20 mg/mL * Total Amount = $1.5 \text{ mL} \times 20 \text{ mg/mL} = 30 \text{ mg}$ 2. **Determine the final plasma concentration (C):** * $C = 0.015 \text{ mg/mL}$ 3. **Calculate Plasma Volume (V):** * $V = 30 \text{ mg} / 0.015 \text{ mg/mL} = 2000 \text{ mL}$ * $2000 \text{ mL} = \mathbf{2 \text{ L}}$ **Analysis of Options:** * **Option B (2 L) is correct** based on the mathematical application of the dilution principle. * **Options A, C, and D** are incorrect as they represent mathematical errors in calculating the total initial mass of the dye or incorrect decimal placement during division. **Clinical Pearls for NEET-PG:** * **Markers for Body Fluid Compartments:** * **Total Body Water:** Heavy water ($D_2O$), Tritiated water, Antipyrine. * **Extracellular Fluid (ECF):** Inulin (Gold Standard), Mannitol, Sucrose. * **Plasma Volume:** Evans Blue (T-1824), Radio-iodinated Serum Albumin (RISA). * **Interstitium:** Cannot be measured directly (ECF minus Plasma Volume). * **Intracellular Fluid:** Cannot be measured directly (Total Body Water minus ECF). * **Rule of Thumb:** In a 70 kg adult, plasma volume is typically ~3–3.5 L (approx. 5% of body weight). However, always solve based on the specific values provided in the question.

Question 9: Calculate the osmolarity of a solution which contains 180 gm of glucose per dL, 117 gm of NaCl per dL, and 56 gm of BUN per dL.

A. 20 osmol/L
B. 30 osmol/L
C. 50 osmol/L
D. 70 osmol/L (Correct Answer)

Explanation: ### Explanation To calculate the osmolarity of a solution, we must determine the number of active particles (osmoles) per liter. The formula used is: **Osmolarity (osmol/L) = [Concentration in g/L ÷ Molecular Weight] × Dissociation factor (n)** First, convert the given concentrations from **per dL (100 mL) to per L (1000 mL)** by multiplying by 10: 1. **Glucose:** 180 g/dL = 1800 g/L. (MW = 180; n = 1). * $1800 / 180 \times 1 = 10 \text{ osmol/L}$ 2. **NaCl:** 117 g/dL = 1170 g/L. (MW = 58.5; n = 2, as NaCl dissociates into $Na^+$ and $Cl^-$). * $1170 / 58.5 \times 2 = 20 \times 2 = 40 \text{ osmol/L}$ 3. **BUN (Urea):** 56 g/dL = 560 g/L. (MW = 28 for Nitrogen; n = 1). * $560 / 28 \times 1 = 20 \text{ osmol/L}$ **Total Osmolarity** = $10 + 40 + 20 = \mathbf{70 \text{ osmol/L}}$. --- #### Why the other options are incorrect: * **Option A (20 osmol/L):** This only accounts for the contribution of BUN or half of the NaCl contribution, ignoring the other solutes. * **Option B (30 osmol/L):** This is the result if one forgets to multiply the NaCl concentration by its dissociation factor (n=2) and uses 10 (Glucose) + 20 (NaCl) + 0 (BUN). * **Option C (50 osmol/L):** This occurs if the student fails to convert deciliters (dL) to liters (L) correctly or misses the contribution of the BUN entirely. --- #### High-Yield Clinical Pearls for NEET-PG: * **Molecular Weights to Remember:** Glucose = 180, Urea = 60 (BUN = 28), NaCl = 58.5. * **Plasma Osmolarity Formula:** $2[Na^+] + \text{Glucose}/18 + \text{BUN}/2.8$. Normal range: 280–295 mOsm/L. * **Effective Osmoles:** Sodium and Glucose are effective osmoles because they stay in the ECF and cause water movement. Urea is an **ineffective osmole** because it crosses cell membranes freely (except in the inner medullary collecting duct). * **Osmolar Gap:** The difference between measured and calculated osmolarity. A gap >10 mOsm/L suggests the presence of unmeasured substances like ethanol, methanol, or ethylene glycol.

Question 10: The kidney plays a role in maintaining the constancy of the milieu interior. What does milieu interior refer to?

A. Extracellular fluid (ECF) (Correct Answer)
B. Intracellular fluid (ICF)
C. Plasma
D. Serum

Explanation: **Explanation:** The term **"Milieu Intérieur"** (Internal Environment) was coined by the French physiologist **Claude Bernard** in the 19th century. It refers specifically to the **Extracellular Fluid (ECF)** that surrounds and bathes the cells. **1. Why ECF is the correct answer:** Cells in multicellular organisms do not live in direct contact with the external atmosphere. Instead, they exist within a "liquid environment"—the ECF. For cells to function optimally, the physical and chemical properties of this fluid (pH, temperature, osmolality, and ion concentrations) must remain constant. This state of stability is known as **Homeostasis** (a term later coined by Walter Cannon). The kidney is the primary organ responsible for regulating the volume and composition of the ECF, thereby maintaining the constancy of the milieu intérieur. **2. Why other options are incorrect:** * **Intracellular Fluid (ICF):** This is the fluid *inside* the cells. While its composition is vital, it is regulated by the cell membrane and the surrounding ECF, rather than being the "internal environment" itself. * **Plasma:** Plasma is a sub-component of the ECF (along with interstitial fluid). While the kidney filters plasma, the term milieu intérieur encompasses the entire fluid environment outside the cells. * **Serum:** Serum is plasma minus clotting factors. It is a laboratory derivative and not a physiological fluid compartment. **High-Yield Facts for NEET-PG:** * **Claude Bernard:** Father of modern physiology; introduced "Milieu Intérieur." * **Walter Cannon:** Coined the term "Homeostasis." * **ECF Volume:** Primarily determined by **Sodium** (the chief extracellular cation). * **Total Body Water (TBW):** 60% of body weight (40% ICF, 20% ECF). The ECF is further divided into Interstitial fluid (3/4th of ECF) and Plasma (1/4th of ECF).

Practice by Chapter

Body Fluid Compartments and Composition

Practice Questions

Osmolality and Tonicity

Practice Questions

Sodium and Water Balance

Practice Questions

Potassium Homeostasis

Practice Questions

Calcium and Phosphate Regulation

Practice Questions

Magnesium Metabolism

Practice Questions

Fluid Shifts Between Compartments

Practice Questions

Edema Formation Mechanisms

Practice Questions

Dehydration Physiology

Practice Questions

Disorders of Electrolyte Balance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free